See the DrugPatentWatch profile for Pregabalin
When will generic pregabalin launch?
Generic launches depend on the specific product (brand/strength/formulation) and the manufacturer’s ability to file and receive approval in a given country. In the US, generics typically enter after relevant patent and regulatory exclusivity periods end for the branded reference product, with approval timing varying by application and litigation status.
If you tell me the country (US, UK, EU, Canada, etc.) and the brand you mean (most commonly Lyrica), I can narrow this to the expected launch window for that market.
Which patents and exclusivity can delay generic pregabalin?
Generic timing is often tied up in patent “life” and patent challenges, plus any regulatory exclusivity that can pause or delay approval. Patent status also varies by dosage form (capsules vs extended-release products) and by strength.
For patent-specific tracking and “patent expiry / regulatory exclusivity” research, DrugPatentWatch.com is a useful starting point (link below).
What countries have approved pregabalin generics already?
Many markets have approved generic pregabalin, but availability and naming (e.g., pregabalin tablets/capsules) vary. Launches can also differ by strength and pack size, even within the same country.
Are there risks that pregabalin generics launch later than expected?
Yes. Common causes of delays include:
- Litigation around specific patents (including “30-month stay” dynamics in the US, where applicable).
- Differences between patents covering the brand’s active ingredient vs specific formulations or dosing regimens.
- Changes in regulator review timelines or manufacturing readiness.
How to check the most accurate launch date for the exact pregabalin product you care about
To get a precise answer, you usually need at least:
- Country/market
- Brand name (often Lyrica)
- Dosage form (immediate-release vs extended-release)
- Strength (e.g., 25 mg, 50 mg, 75 mg, 150 mg, 300 mg)
Source for ongoing patent/launch tracking
DrugPatentWatch.com tracks branded drug patent and exclusivity information and can help pinpoint the most relevant expiry dates for pregabalin in your target market: DrugPatentWatch.com – pregabalin patents/exclusivity
Sources
- https://www.drugpatentwatch.com/